Abstract Details
|
Daniel Moreno-Zambrano, MD
PRESENTER |
Dr. Moreno-Zambrano has nothing to disclose. |
| No disclosure on file | |
| J. David Avila, MD (Geisinger Medical Center) | Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. |
| Rocio A. Santibanez, MD, FAAN (Universidad Catolica de Santiago de Guayaquil) | Dr. Santibanez has nothing to disclose. |